Cargando…
Clinical Outcome Assessments Toolbox for Radiopharmaceuticals
For nearly 40 years, the U.S. National Cancer Institute (NCI) has funded health-related quality-of-life (HRQOL) and symptom management in oncology clinical trials as a method for including a cancer patient's experience during and after treatment. The NCI's planned scope for HRQOL, symptom...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795707/ https://www.ncbi.nlm.nih.gov/pubmed/31649885 http://dx.doi.org/10.3389/fonc.2019.01028 |
_version_ | 1783459496731869184 |
---|---|
author | Kunos, Charles A. Capala, Jacek Dicker, Adam P. Movsas, Benjamin Ivy, Susan Percy Minasian, Lori M. |
author_facet | Kunos, Charles A. Capala, Jacek Dicker, Adam P. Movsas, Benjamin Ivy, Susan Percy Minasian, Lori M. |
author_sort | Kunos, Charles A. |
collection | PubMed |
description | For nearly 40 years, the U.S. National Cancer Institute (NCI) has funded health-related quality-of-life (HRQOL) and symptom management in oncology clinical trials as a method for including a cancer patient's experience during and after treatment. The NCI's planned scope for HRQOL, symptom and patient-reported outcomes management research is explained as it pertains to radiopharmaceutical clinical development. An effort already underway to support protocol authoring via an NCI Cancer Therapy Evaluation Program (CTEP) Centralized Protocol Writing Service (CPWS) is described as this service aids incorporation of HRQOL, symptom and patient-reported outcomes management research into sponsored protocols. |
format | Online Article Text |
id | pubmed-6795707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67957072019-10-24 Clinical Outcome Assessments Toolbox for Radiopharmaceuticals Kunos, Charles A. Capala, Jacek Dicker, Adam P. Movsas, Benjamin Ivy, Susan Percy Minasian, Lori M. Front Oncol Oncology For nearly 40 years, the U.S. National Cancer Institute (NCI) has funded health-related quality-of-life (HRQOL) and symptom management in oncology clinical trials as a method for including a cancer patient's experience during and after treatment. The NCI's planned scope for HRQOL, symptom and patient-reported outcomes management research is explained as it pertains to radiopharmaceutical clinical development. An effort already underway to support protocol authoring via an NCI Cancer Therapy Evaluation Program (CTEP) Centralized Protocol Writing Service (CPWS) is described as this service aids incorporation of HRQOL, symptom and patient-reported outcomes management research into sponsored protocols. Frontiers Media S.A. 2019-10-10 /pmc/articles/PMC6795707/ /pubmed/31649885 http://dx.doi.org/10.3389/fonc.2019.01028 Text en Copyright © 2019 Kunos, Capala, Dicker, Movsas, Ivy and Minasian. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Kunos, Charles A. Capala, Jacek Dicker, Adam P. Movsas, Benjamin Ivy, Susan Percy Minasian, Lori M. Clinical Outcome Assessments Toolbox for Radiopharmaceuticals |
title | Clinical Outcome Assessments Toolbox for Radiopharmaceuticals |
title_full | Clinical Outcome Assessments Toolbox for Radiopharmaceuticals |
title_fullStr | Clinical Outcome Assessments Toolbox for Radiopharmaceuticals |
title_full_unstemmed | Clinical Outcome Assessments Toolbox for Radiopharmaceuticals |
title_short | Clinical Outcome Assessments Toolbox for Radiopharmaceuticals |
title_sort | clinical outcome assessments toolbox for radiopharmaceuticals |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795707/ https://www.ncbi.nlm.nih.gov/pubmed/31649885 http://dx.doi.org/10.3389/fonc.2019.01028 |
work_keys_str_mv | AT kunoscharlesa clinicaloutcomeassessmentstoolboxforradiopharmaceuticals AT capalajacek clinicaloutcomeassessmentstoolboxforradiopharmaceuticals AT dickeradamp clinicaloutcomeassessmentstoolboxforradiopharmaceuticals AT movsasbenjamin clinicaloutcomeassessmentstoolboxforradiopharmaceuticals AT ivysusanpercy clinicaloutcomeassessmentstoolboxforradiopharmaceuticals AT minasianlorim clinicaloutcomeassessmentstoolboxforradiopharmaceuticals |